XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 38.55

Change

+0.23 (+0.60)%

Market Cap

CAD 0.46B

Volume

2.51K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-21 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

-0.09 (-0.07%)

CAD 14.34B
ZSP:CA BMO S&P 500

-0.01 (-0.01%)

CAD 13.97B
XSP:CA iShares Core S&P 500 (CAD Hedg..

+0.01 (+0.02%)

CAD 10.00B
VUN:CA Vanguard US Total Market

-0.24 (-0.24%)

CAD 8.46B
XUS:CA iShares Core S&P 500 Index ETF

N/A

CAD 6.28B
HXS:CA Global X S&P 500® Index Corpo..

-0.10 (-0.13%)

CAD 3.58B
VSP:CA Vanguard S&P 500 CAD hedged

-0.09 (-0.10%)

CAD 3.21B
QUU:CA Mackenzie US Large Cap Equity ..

+0.26 (+0.12%)

CAD 3.00B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

+0.58 (+0.39%)

CAD 2.84B
XUU:CA iShares Core S&P US Total Mark..

-0.11 (-0.20%)

CAD 2.84B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.35% 88% B+ 78% C+
Dividend Return 0.23% 18% F 6% D-
Total Return 15.58% 91% A- 77% C+
Trailing 12 Months  
Capital Gain 29.10% 79% B- 82% B
Dividend Return 1.28% 35% F 23% F
Total Return 30.38% 77% C+ 82% B
Trailing 5 Years  
Capital Gain 91.89% 89% A- 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 91.89% 75% C 80% B-
Average Annual (5 Year Horizon)  
Capital Gain 12.83% 88% B+ 81% B-
Dividend Return 13.54% 81% B- 80% B-
Total Return 0.71% 20% F 29% F
Risk Return Profile  
Volatility (Standard Deviation) 13.98% 50% F 57% F
Risk Adjusted Return 96.84% 78% C+ 97% N/A
Market Capitalization 0.46B 62% D 60% D-

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.